Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
43
43 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AmlitelimabSAR445229Phase 39 trials
Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease
- FrexalimabSAR441344Phase 39 trials
Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
- ItepekimabREGN3500, SAR440340Phase 39 trials
Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis
- LunsekimigSAR443765Phase 39 trials
Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps
- DuvakitugSAR447189, TEV-48574 APhase 36 trials
Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis
- PCV21 vaccinePhase 35 trials
Sanofi · Pneumococcal Immunization, Healthy Volunteers
- SAR445088Riliprubart, BIVV020Phase 35 trials
Sanofi · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic, Transplant Rejection
- VenglustatGZ402671Phase 35 trials
Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- MenACYW conjugate vaccineNimenrixPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization
- BIVV001efanesoctocog, AltuvoctPhase 33 trials
Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe
- bypassing agentsClotting factor concentrates, CFCPhase 33 trials
Sanofi · Hemophilia, Von Willebrand Disease, Type 3
- M-M-R II vaccinePhase 33 trials
Sanofi · Pneumococcal Immunization
- MRI contrast-enhancing agentsPhase 33 trials
Sanofi · Multiple Sclerosis
- poliomyelitis vaccinePhase 33 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria
- TolebrutinibSAR442168Phase 33 trials
Sanofi · Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
- calcineurin inhibitorsPhase 32 trials
Sanofi · Dermatitis Atopic
- HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials
Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
- MRI contrast-enhancing preparationsPhase 32 trials
Sanofi · Multiple Sclerosis
- NVXC19EU licensed, standalonePhase 31 trial
Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- EvorpaceptALX148Phase 25 trials
ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic
- ADG126Phase 23 trials
Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers
- Antithymocyte globulinATGPhase 22 trials
Sanofi · Transplant Rejection, Renal Transplantation
- Fluzone QudrivalentPhase 22 trials
Sanofi · Healthy Volunteers, Influenza Immunization, Influenza
- hMPV vaccinePhase 22 trials
Sanofi · Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization, Healthy Volunteers
- Pentavalent Meningococcal ABCYW vaccineMenPentaPhase 22 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Meningococcal Immunisation
- rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials
Sanofi · COVID-19 Immunization, Influenza Immunization
- RSV vaccine candidatePhase 22 trials
Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization
- SAR445877Phase 22 trials
Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma
- SAR447537Phase 22 trials
Sanofi · Alpha 1-Antitrypsin Deficiency, Emphysema
- PegenzileukinSAR444245Phase 21 trial
Sanofi · Plasma Cell Myeloma Refractory
- SAR402663Phase 21 trial
Sanofi · Neovascular Age-related Macular Degeneration
- SAR439459Phase 21 trial
Sanofi · Plasma Cell Myeloma Refractory
- SAR441566Phase 21 trial
Sanofi · Rheumatoid Arthritis
- SAR443122Phase 21 trial
Sanofi · Colitis Ulcerative
- SAR444336Phase 21 trial
Sanofi · Microscopic Colitis
- SAR444836Phase 21 trial
Sanofi · Phenylketonuria
- SAR445399Phase 21 trial
Sanofi · Hidradenitis Suppurativa
- SAR446268Phase 21 trial
Sanofi · Myotonic Dystrophy
- SAR446597Phase 21 trial
Sanofi · Geographic Atrophy
- SAR448851Phase 21 trial
Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.